Both in Pharmaceuticals
Corvus Pharmaceuticals vs Pacira BioSciences
Over the past year CRVS returned +61.5% and PCRX returned +1.2%; their daily moves had a correlation of 0.08.
CRVS +61.5% PCRX +1.2%Growth of $1, one year, split-adjusted
| Metric | CRVS | PCRX |
|---|---|---|
| Price | $11.76 | $25.65 |
| Market cap | $989.3M | $1.02B |
| Today | −0.93% | +1.02% |
| 1 month | −16.9% | −0.4% |
| 6 months | −12.2% | +10.2% |
| Year to date | +52.7% | −0.9% |
| 1 year | +59.1% | +1.6% |
| Revenue growth (YoY) | — | +6.2% |
| Gross margin | — | 77.0% |
| Net margin | — | 2.4% |
| P/E (TTM) | — | 69.8× |
| Price / sales | — | 1.4× |
| Net cash | $215.2M | -$112.1M |
| Dividend yield | — | — |
| Volatility (60d) | 51.1% | 35.7% |
| Short % of float | 24.4% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).